|
FDA Releases List of Drugs Posing "Potential Safety Issues" Friday September 5, 2008 NEWSBRIEF: The FDA has released its first quarterly list of drugs that under investigation for posting "potential safety issues." The list includes: Cymbalta (duloxetine), an antidepressant also approved for fibromyalgia Dilantin (phenetoin injection), an antiseizure drug Seroquel (quetiapine), an antipsychotic Tumor Necrosis Factor (TNF) Blockers, such as Enbrel (etanercept), Remicade (infliximab), and Humira (adalimumab), used for arthritis Humulin R (Insulin U-500), for diabetes A drug's appearance on the list doesn't mean the FDA has found it to be dangerous, but means being examined for potential problems. The FDA has begun posting this list as part of the 2007 Food and Drug Administration Amendments Act. See the entire list Report an adverse reaction to the FDA Related Content: Drug Treatments for Fibromyalgia & Chronic Fatigue Syndrome http://chronicfatigue.about.com/b/2008/09/05/fda-releases-
list-of-drugs-posing-potential-safety-issues.htm?r=94 |
"MDJunction to me has been the helping friends of understanding that I have needed. I feel now as if someone else it the world understands the things that I am going through. I feel less alone and happier. Here I can let out all my emotions and get support from many people who have been in similar situations. It really has been a life saver for me!" (Amanda78)